CliffBio
small molecule

WELCHOL

COLESEVELAM HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyCosette Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameWELCHOL
Active ingredientCOLESEVELAM HYDROCHLORIDE
Strength3.75GM
Dosage formBAR, CHEWABLE
RouteORAL
ModalitySmall molecule
FDA approvalApril 2019
Marketing statusDISCN

More from Cosette Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

WELCHOL patent cliff — loss of exclusivity — | CliffBio